| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K30748066 |
| PharmacoGx | BRD-K30748066 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ERAL1 | CTRPv2 | pan-cancer | AAC | 0.54 | 0.0004 |
| mRNA | SRRT | CTRPv2 | pan-cancer | AAC | 0.41 | 0.0004 |
| mRNA | IL2RA | CTRPv2 | pan-cancer | AAC | 0.36 | 0.0004 |
| mRNA | PSTPIP1 | CTRPv2 | pan-cancer | AAC | 0.39 | 0.0004 |
| mRNA | NDUFA4 | CTRPv2 | pan-cancer | AAC | 0.41 | 0.0004 |
| mRNA | TIMM21 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.0004 |
| mRNA | RAB44 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.0004 |
| mRNA | C1orf162 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.0005 |
| mRNA | TIMM50 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.0005 |
| mRNA | P2RY13 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.0005 |
